Single-session radiosurgery for Cushing disease after failed resection: a retrospective single-center cohort study
The Journal of Clinical Endocrinology & Metabolism · 10.11.2026
DOI: 10.1210/clinem/dgag369 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 10.11.2026. Verfasst von Bardia Hajikarimloo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, University of Virginia, Charlottesville, VA 22908, USA. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Context
Cushing disease (CD) from an adrenocorticotropic hormone-secreting pituitary adenoma causes substantial morbidity when hypercortisolism persists or recurs after transsphenoidal surgery (TSS).
Objective
To define endocrine control, radiographic response, toxicity, and predictors after single-session Gamma Knife radiosurgery for residual or recurrent CD.
Design
Retrospective single-center cohort study, 1990-2026; median endocrine follow-up 54 months.
Setting
Single academic tertiary referral center. Patients 186 adults with residual or recurrent CD after ≥1 TSS and ≥12 months of follow-up. Median age 40.8 years; 78.0% female.
Intervention
Single-session frame-based SRS (median prescription dose 23.0 Gy; maximum dose 48.0 Gy). Main Outcome Measures Prespecified primary outcome was durable biochemical control off medications (sustained 24-hour urinary free cortisol [UFC] normalization without cortisol-lowering therapy), modeled with competing-risks methodology.
Results
UFC normalized in 152 patients (81.7%), including 134 (72.0%) off all medications. Cumulative incidence of durable off-medication control was 51% (95% CI: 44-58%) at 12 months and 64% (95% CI: 56-71%) at 120 months. New endocrinopathy reached 42% (95% CI: 32-52%) at 120 months; new visual deficit occurred in 3.2%. A TSS-to-SRS interval <6 months independently predicted higher durable control (P < .001), while higher baseline AM cortisol (P < .001), whole-sella treatment (P = .013), and female gender (P = .027) predicted lower durable control. Higher maximum dose was the sole independent predictor of new endocrinopathy (P = .009).
Conclusion
Single-session SRS achieves durable medication-free control in approximately two-thirds of patients with residual or recurrent CD, with excellent tumor control and meaningful delayed endocrine toxicity warranting long-term surveillance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurological Surgery, University of Virginia, Charlottesville, VA 22908, USA.
- Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia, Charlottesville, VA 22903, USA.
ORCID-Profile: Bardia Hajikarimloo, Salem M Tos, Yuki Shinya, Onam Verma, Georgios Mantziaris, Gregory K Hong, Jason P Sheehan
Zitieren
APA
Hajikarimloo, B., Tos, S. M., Shinya, Y., Verma, O., Mancini, E., Morgan, S., Li, Z., Mantziaris, G., Hong, G. K., & Sheehan, J. P. (2026). Single-session radiosurgery for Cushing disease after failed resection: a retrospective single-center cohort study. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag369
Vancouver
Hajikarimloo B, Tos SM, Shinya Y, Verma O, Mancini E, Morgan S, et al. Single-session radiosurgery for Cushing disease after failed resection: a retrospective single-center cohort study. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag369
BibTeX
@article{Hajikarimloo2026,
author = {Hajikarimloo, Bardia and Tos, Salem M and Shinya, Yuki and Verma, Onam and Mancini, Evan and Morgan, Sean and Li, Zhenye and Mantziaris, Georgios and Hong, Gregory K and Sheehan, Jason P},
title = {Single-session radiosurgery for Cushing disease after failed resection: a retrospective single-center cohort study},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgag369}
}
EUVIMED